Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 131

1.

[The effect of retrovirus-mediated HO-1 gene on chronic myeloid leukemia resistance cell K562/A02 apoptosis induced by nilotinib].

Chen C, Wang JS, Qin D, Yang Y, Yu YY, Fang Q.

Zhonghua Xue Ye Xue Za Zhi. 2012 May;33(5):383-7. Chinese.

PMID:
22781797
2.

[Effects of HO-1 gene expression on proliferation of imatinib resistant CML cells].

Wang JS, Chai BS, Fang Q, He YY, Chen C, Yang C.

Zhonghua Xue Ye Xue Za Zhi. 2011 Jun;32(6):388-91. Chinese.

PMID:
21781496
3.

[CML cell apoptosis induced by AMN107 combined with heme oxygenase-1 inhibitor].

Chen C, Wang JS, Ynag C, Yu YY, Li Y, Ma D, Fang Q.

Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2012 Aug;20(4):867-71. Chinese.

PMID:
22931644
4.

[K562 cell line resistance to nilotinib induced in vitro and preliminary investigation of its mechanisms].

Wang JS, Yang C, Fang Q, Wei SX, Chen C, Yang Y, Wang YT, Hu XY, Ma D.

Zhonghua Xue Ye Xue Za Zhi. 2012 Nov;33(11):906-10. Chinese.

PMID:
23363745
5.

[Inducing apoptosis and reversal effect of nilotinib in combination with tetrandrine on multidrug resistance of K562/A02 cell line].

Cui TY, Chen BA, Ding JH, Gao C, Cheng J, Bao W, Zhong YJ, Shan XY, Gao F, Xia GH, Schmitt A, Schmitt M.

Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2011 Feb;19(1):28-33. Chinese.

PMID:
21362216
6.

Effects of imatinib and 5-bromotetrandrine on the reversal of multidrug resistance of the K562/A02 cell line.

Chen BA, Shan XY, Chen J, Xia GH, Xu WL, Schmit M.

Chin J Cancer. 2010 Jun;29(6):591-5.

7.

[Influence of YB-1 protein on the biological behaviour in K562/A02 cells].

Shen HL, Zhou LL, Chen QY, Chen C, Fang LL, Fang XJ, Xu WL.

Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2011 Apr;19(2):342-7. Chinese.

PMID:
21518485
8.

[Effects of specific siRNA targeting at bcr-abl fusion gene and its combination with p27 gene clone on chronic myeloid leukemia cell line K562].

Wang W, DU Y, Lin GQ, Li NN, Sun BZ.

Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2010 Jun;18(3):606-11. Chinese.

PMID:
20561411
9.

[Effect of desferrioxamine on K562/A02 cell line and its mechanism].

Cheng J, Wang T, Chen BA, Ding JH, Gao C, Xia GH, Bao W, Song HH, Xu WL, Shen HL.

Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2011 Apr;19(2):337-41. Chinese.

PMID:
21518484
10.

[Effect of CD44 gene silence on multi-drug resistance reversal and biologic activity in K562/A02 cells].

Liu YP, Liu CF, Ma DX, Lu F, Zhang JJ, Kong HL.

Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2010 Apr;18(2):335-9. Chinese.

PMID:
20416163
11.

[Study on reversal effect of nilotinib in combination with 5-BrTet on multidrug resistance of K562/A02 cell line].

Chen BA, Shan XY, Chen J, Wang F, Ding JH, Gao C, Zhao G, Wang XM, Xu WL, Gao F, Xia GH, Schmitt M.

Zhonghua Xue Ye Xue Za Zhi. 2010 Jun;31(6):385-8. Chinese.

PMID:
21122353
12.

[Reversal of multidrug-resistance in human leukemia cell line K562/A02 by tyrosine kinase inhibitors].

Shan XY, Chen BA, Xia GH, Xu WL, Ding JH, Gao C, Sun YY, Wang J, Cheng J, Zhao G, Bao W, Song HH, Gao F, Wang F, Wang XM.

Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2010 Feb;18(1):90-5. Chinese.

PMID:
20137125
13.

[Effect of YB-1 gene knockdown on human leukemia cell line K562/A02].

Xu WL, Zhou LL, Chen QY, Chen C, Fang LL, Fang XJ, Shen HL.

Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2009 Aug;26(4):400-5. Chinese.

PMID:
20017303
14.

[Enhancive effect of PLK1 gene silencing on sensitivity of K562/A02 cells to adriamycin].

Liu L, Zhang M, Zou P, Tian L, Liu F.

Ai Zheng. 2006 Apr;25(4):404-8. Chinese.

PMID:
16613670
15.

[Effect of hypoxia inducible factor1-α inhibitor on reversal of multidrug resistance of K562/A02 cell line].

Chen BA, Wang F, Cheng J, Ding JH, Gao C, Sun YY, Wang J, Zhao G, Bao W, Song HH, Gao F, Xia GH, Shan XY.

Zhonghua Xue Ye Xue Za Zhi. 2010 Jun;31(6):389-93. Chinese.

PMID:
21122354
16.

Identification of heme oxygenase-1 as a novel BCR/ABL-dependent survival factor in chronic myeloid leukemia.

Mayerhofer M, Florian S, Krauth MT, Aichberger KJ, Bilban M, Marculescu R, Printz D, Fritsch G, Wagner O, Selzer E, Sperr WR, Valent P, Sillaber C.

Cancer Res. 2004 May 1;64(9):3148-54.

17.

[Reversal of multi-drug resistance in K562/A02 cells by two short hairpin RNAs (shRNA) of mdr1].

Yu HQ, Ji CY, Ma DX, Zang SL.

Zhonghua Xue Ye Xue Za Zhi. 2006 Jul;27(7):456-60. Chinese.

PMID:
17147248
18.

[Overexpression of Shp-2 is associated with the unlimited growth and apoptosis resistance of p210 bcr-abl-mediated chronic myeloid leukemia].

Zhu XZ, Yu YZ, Fang YM, Liang Y, Lü QH, Xu RZ.

Zhonghua Yi Xue Za Zhi. 2005 Jul 20;85(27):1903-6. Chinese.

PMID:
16255985
19.

Inhibition of phosphotyrosine phosphatase 1B causes resistance in BCR-ABL-positive leukemia cells to the ABL kinase inhibitor STI571.

Koyama N, Koschmieder S, Tyagi S, Portero-Robles I, Chromic J, Myloch S, Nürnberger H, Rossmanith T, Hofmann WK, Hoelzer D, Ottmann OG.

Clin Cancer Res. 2006 Apr 1;12(7 Pt 1):2025-31.

20.

[Construction of retrovirus vector of bcr/abl mRNA cleaving ribozyme gene and its effects on K562 cells].

Wu Y, Chen Y, Hu J.

Zhonghua Xue Ye Xue Za Zhi. 1998 Dec;19(12):623-6. Chinese.

PMID:
11263328

Supplemental Content

Support Center